7 Critical Questions to Ask Before Buying an AI Scribe

TL;DR: Purchasing the wrong AI scribe can cost your organization months of lost productivity, compliance exposure, and clinician trust. Before you sign any contract, your procurement team should pressure-test vendors against seven critical questions spanning clinical accuracy, EHR integration depth, HIPAA and data privacy safeguards, real-world workflow fit, reporting and ROI measurement, contract flexibility, and specialty adaptability. This guide gives you the exact questions to ask, what good and bad answers sound like, and the red flags that should stop a deal. Use it as your vendor-neutral evaluation framework, then see how Scribing.io stacks up by reviewing our transparent pricing.

Key Takeaways:

• 7 make-or-break questions organized by risk category

• "Good answer vs. bad answer" benchmarks for each question

• Red-flag checklist to bring into every vendor demo

• Procurement-ready scoring criteria for side-by-side comparison

• Answers to common procurement objections in the FAQ

AI scribe demos are engineered to impress. Quiet rooms, cooperative patients, clean audio, a single speaker narrating a textbook HPI. The vendor clicks a button, a polished SOAP note appears, and your evaluation team nods approvingly. But clinical reality includes overlapping speakers, specialty jargon, mid-visit interruptions, crying children, thick accents, and EHR systems that don't play nicely with third-party tools. Procurement teams who skip structured evaluation end up buying the demo, not the product.

Platforms like Scribing.io have been deployed across family medicine, psychiatry, cardiology, and pediatric practices—giving us a front-row view of what separates successful AI scribe implementations from expensive shelf-ware. This guide distills that experience into a vendor-neutral framework: seven critical questions every healthcare organization should ask before signing an AI scribe contract. If you're evaluating AI scribes specifically for primary care workflows, see our deep dive on AI scribes in family medicine.

Table of Contents

• Why Healthcare Procurement Teams Keep Getting AI Scribe Purchases Wrong

• Question 1 — How Accurate Is the AI Scribe in Real Clinical Conditions?

• Question 2 — How Deep Is the EHR Integration?

• Question 3 — How Does It Perform in Real-World Clinical Workflows?

• Question 4 — What Are the HIPAA and Data Privacy Safeguards?

• Question 5 — How Do You Measure and Report ROI?

• Question 6 — What Does the Contract Actually Lock You Into?

• Question 7 — How Well Does It Adapt to My Specialty and Setting?

• How to Score Vendors Side by Side

• FAQ: Common Procurement Objections

• Get Started Today

Why Healthcare Procurement Teams Keep Getting AI Scribe Purchases Wrong

The Demo-to-Reality Gap

Every AI scribe vendor can produce an impressive demo. The problem is that demos are controlled environments. They don't replicate the acoustic chaos of a busy urgent care clinic, the rapid code-switching of a bilingual patient encounter, or the way a cardiologist abbreviates medication names that even pharmacists argue about. A 2024 AMA survey on physician technology adoption found that clinician satisfaction with health IT tools drops sharply when real-world performance diverges from what was shown during evaluation. AI scribes are no exception.

The vendors who thrive long-term are the ones who invite you to test in your messiest environment—not their cleanest one. If a vendor resists a pilot in your actual clinic with your actual patients, that tells you everything.

The True Cost of Choosing the Wrong AI Scribe

The financial cost of a bad AI scribe purchase extends far beyond the license fee. Consider the compounding damage:

• Clinician abandonment: Physicians who lose trust in a tool within the first two weeks rarely return. You've now spent onboarding resources on a product that will collect dust.

• Rework hours: If clinicians must edit every note extensively, the scribe isn't saving time—it's adding a review step to an already burdened workflow.

• Compliance risk: Inaccurate medication documentation, hallucinated diagnoses, or notes attributed to the wrong patient create liability exposure that no vendor indemnification clause fully covers.

• Contract lock-in: Multi-year agreements with steep early-termination penalties trap organizations in relationships with underperforming products.

• The hidden cost of "good enough" accuracy: An AI scribe that's right 90% of the time sounds acceptable—until you realize it means errors in roughly three notes per physician per day across a busy panel.

What a Structured Evaluation Actually Looks Like

The seven questions in this guide are organized by risk category: clinical safety, technical integration, workflow fit, compliance, financial accountability, contractual flexibility, and specialty adaptability. For each question, we provide the exact sub-questions to ask vendors, examples of what strong and weak answers look like, and deal-breaking red flags. Understanding your state's AI scribe regulations matters—see AI scribe laws in California for a compliance example relevant to state-level evaluation.

Question 1 — How Accurate Is the AI Scribe in Real Clinical Conditions, and How Do You Measure It?

Clinical accuracy isn't just a feature—it's the foundation of patient safety. A scribe that hallucinates a medication, omits a critical allergy, or misattributes a symptom to the wrong body system creates risk that compounds across every downstream decision.

What to Ask the Vendor

• What is your transcription and note-generation accuracy rate, and how is it measured?

• How do you handle medical terminology, abbreviations, medications, and dosing?

• What are your known failure modes—hallucinations, omissions, attribution errors?

• Do you provide confidence scoring or uncertainty flagging on high-risk note sections like medications, assessment, and plan?

• Can you share error-category data from existing deployments?

What Good Answers Sound Like

A credible vendor will explain their accuracy methodology in detail. They'll distinguish between word-error-rate on raw transcription (a narrow metric) and clinical note fidelity assessed through clinician-reviewed audits. They'll acknowledge that no AI system is perfect and show you the safeguards: confidence flags that highlight uncertain sections, structured templates that surface missing required elements, and the ability to lock custom terminology dictionaries for your organization.

Strong vendors also provide transparency around their training data and model governance, aligning with recommendations from organizations like NEJM on clinical AI validation.

What Bad Answers Sound Like

• "Our accuracy is 99%." Without specifying what's being measured, over what sample, and who assessed it, this number is meaningless.

• "We don't see hallucinations." Every large language model can hallucinate. A vendor who denies this either hasn't looked or doesn't want you to.

• "It works best if clinicians speak more clearly." This shifts the burden of accuracy from the product to the user—a sign of immaturity.

Red Flags

• No audit tooling or error-trend reporting available to your organization

• No ability to lock custom terminology or abbreviation mappings

• Dismisses medication and dosing accuracy risk as edge cases

Scribing.io surfaces confidence flags on high-risk note sections and supports specialty-specific medical dictionaries. See how this works in practice for psychiatry documentation, where terminology precision is especially critical.

Question 2 — How Deep Is the EHR Integration, and What Actually Writes Back?

EHR integration is the single biggest determinant of long-term adoption. A scribe that generates a flawless note but requires copy-paste into your EHR will be abandoned within weeks—clinicians already have too many tabs open.

What to Ask the Vendor

• Which EHR systems do you integrate with today—not on your roadmap?

• What data do you read from the EHR (patient context, visit type, problem list, medications)?

• What data do you write back (complete note, structured data fields, codes, attachments)?

• Does the note land in the correct patient record without manual matching?

• What is the integration model: direct API, certified marketplace app, browser extension, or copy-paste?

What Good Answers Sound Like

"We write the note directly into your EHR via a certified API integration, mapped to the correct visit and note section. We support bi-directional data flow—pulling patient context like the active problem list and medication list to improve note quality, then pushing the finalized and clinician-approved note back into the chart." This level of integration aligns with the ONC interoperability requirements that increasingly govern health IT procurement.

What Bad Answers Sound Like

• "We integrate—you can export." Export is not integration.

• "Copy and paste is fast." Fast isn't the problem. Manual steps introduce error and clinician friction.

• "We support Epic—it's on our roadmap." Roadmap items aren't features. They're aspirations.

Red Flags

• Copy-paste is the only workflow option

• No current integration with your EHR; only "coming soon"

• Cannot write into structured data fields—only free-text note sections

For Epic-specific integration considerations, read AI scribe for Epic: what to know before you buy. If your organization runs athenahealth, we cover that in AI scribe for athenahealth.

View Scribing.io Pricing

Question 3 — How Does the AI Scribe Perform in Real-World Clinical Workflows?

Accuracy and integration matter, but they're meaningless if the tool breaks when confronted with how medicine is actually practiced.

What to Ask the Vendor

• Walk me through the full workflow from "start recording" to a signed note in the EHR.

• How does the scribe handle multi-speaker environments (interpreter, medical assistant, family members)?

• Does it support telehealth, in-person, and hybrid visit types?

• What happens when the clinician steps out and returns—does the note remain coherent?

• Can the clinician edit, append, or reject sections before the note is finalized?

• How does it handle mid-visit interruptions, phone calls, or context switches?

What Good Answers Sound Like

A vendor with real-world deployment experience will describe graceful handling of messy scenarios. They'll explain speaker diarization—the ability to distinguish the physician's voice from the patient, interpreter, and medical assistant. They'll show you how the note handles pauses, interruptions, and resumed conversations without duplicating or omitting content. They'll demonstrate telehealth workflows alongside in-person workflows and show that both produce clinically complete notes.

What Bad Answers Sound Like

• "It works best in one-on-one visits." Most visits involve more than two people speaking.

• "The clinician can always edit afterward." This isn't a workflow answer—it's an escape hatch.

• "We recommend the clinician summarize at the end." If the physician has to dictate a summary, you've bought an expensive transcription tool, not a scribe.

Red Flags

• No speaker diarization capability

• Telehealth is listed as a separate, premium add-on

• The vendor cannot provide a live demo with overlapping speakers or background noise

• No clinician review step before the note is committed to the chart

Question 4 — What Are the HIPAA and Data Privacy Safeguards?

AI scribes process some of the most sensitive data in healthcare: the unfiltered, spoken content of a clinical encounter. Your evaluation must go beyond "Are you HIPAA compliant?" to interrogate data handling at the architectural level.

What to Ask the Vendor

• Where is audio data processed—on-device, in your cloud, or via a third-party API?

• How long is audio retained, and who has access to it?

• Do you use patient encounter data to train your models? If so, how is consent and de-identification handled?

• Will you sign a Business Associate Agreement (BAA) that explicitly covers AI-generated content?

• How do you handle data residency requirements for organizations subject to state-specific privacy laws?

• What happens to our data if we terminate the contract?

What Good Answers Sound Like

Strong vendors provide architectural transparency. They'll explain their data flow diagram—where audio is captured, where it's transmitted, where processing occurs, and when it's deleted. They'll have a clear data retention policy measured in hours or days, not months. They'll sign a BAA without hesitation and address model training with specifics: "We do not use individual customer encounter data for model training" or "We use de-identified, aggregated data with opt-out available." This aligns with the HHS guidance on HIPAA and artificial intelligence.

What Bad Answers Sound Like

• "We're HIPAA compliant." This is a claim, not evidence. Ask for the SOC 2 Type II report, penetration test results, and the signed BAA template.

• "Audio is deleted after processing." Deleted from where? By whom? Under what SLA?

• "We may use de-identified data to improve our models." Without specifics on de-identification methodology, this is a liability landmine.

Red Flags

• Audio is processed through consumer-grade APIs (e.g., generic cloud speech-to-text) without a healthcare-specific BAA

• Vendor cannot produce SOC 2 Type II certification

• No clear answer on data deletion timelines post-contract termination

• Model training uses identifiable patient data without explicit opt-in consent

Try Scribing.io Free

Question 5 — How Do You Measure and Report ROI?

Every AI scribe vendor claims to save time. Few provide the tools to prove it. If you can't measure the impact, you can't justify the renewal—and your CFO will notice.

What to Ask the Vendor

• What analytics dashboard or reporting tools are included?

• Can you track time-to-note-completion before and after deployment?

• Do you report on clinician adoption rates, edit rates, and note rejection rates?

• Can your reporting distinguish between departments, specialties, and individual clinicians (where appropriate)?

• Do you provide a baseline measurement methodology for pre-deployment comparison?

What Good Answers Sound Like

A mature vendor offers an administrative dashboard that tracks meaningful operational metrics: average time from encounter start to signed note, percentage of notes accepted without edits, adoption rates by department, and trend data over time. They'll help you establish pre-deployment baselines so you can quantify the before-and-after impact. Some vendors also track downstream indicators like whether documentation completeness has improved coding accuracy—tying documentation quality to revenue cycle performance. For ICD-10 coding, this connection between AI-generated notes and correct code capture is especially valuable.

What Bad Answers Sound Like

• "Clinicians report saving two hours per day." Self-reported estimates are unreliable. You need system-measured data.

• "We can provide case studies." Case studies are marketing materials, not operational analytics. You need your own data from your own deployment.

• "ROI is self-evident." Nothing in healthcare procurement is self-evident. This is a dodge.

Red Flags

• No analytics dashboard available to administrators

• Reporting is limited to usage counts (number of encounters recorded) without quality or efficiency metrics

• Vendor cannot articulate a methodology for measuring pre-vs.-post deployment impact

Question 6 — What Does the Contract Actually Lock You Into?

AI scribe technology is evolving rapidly. A contract that made sense in 2025 may be an anchor by 2027. Your procurement team needs to negotiate flexibility—not just features.

What to Ask the Vendor

• What is the minimum contract term, and what are the early termination penalties?

• Is there a pilot or proof-of-concept period with defined success criteria?

• How is pricing structured—per clinician, per encounter, per organization?

• What happens to pricing if we scale up or down?

• Do you offer performance-based exit clauses (e.g., if accuracy drops below an agreed threshold, we can terminate)?

• Who owns the notes and data generated during the contract?

What Good Answers Sound Like

"We offer a 30-day free pilot with defined success criteria we set together. Our standard contract is annual with 90-day termination notice and no penalty. Pricing is per-clinician per-month, with volume discounts at defined tiers. All notes generated are your data—you retain full ownership, and we provide a complete data export upon termination." This is the kind of flexibility that signals a vendor confident in their product's performance.

What Bad Answers Sound Like

• "We require a 3-year commitment for the best pricing." In a market this dynamic, three years is an eternity. Negotiate hard.

• "Pricing is custom—let's discuss after you see the demo." Opacity in pricing usually means you'll pay more than you should. The AMA's principles for augmented intelligence in healthcare emphasize transparency as a foundational requirement.

• "We don't do pilots." A vendor who won't let you test the product in your environment has something to hide.

Red Flags

• No pilot or proof-of-concept option

• Early termination penalties exceed six months of fees

• Vendor retains ownership or usage rights over generated clinical documentation

• Pricing is only available after a sales call—never published publicly

Scribing.io publishes transparent pricing and offers a free trial with no credit card required. We believe if we can't prove value during a pilot, we haven't earned the contract.

Question 7 — How Well Does the AI Scribe Adapt to My Specialty and Care Setting?

A scribe built for primary care documentation may produce unusable notes in dermatology, psychiatry, or cardiology. Specialty workflows differ in structure, terminology, required documentation elements, and regulatory requirements. Your AI scribe must adapt to how your clinicians practice—not force your clinicians to adapt to it.

What to Ask the Vendor

• Which specialties do you actively support today with specialty-specific templates and terminology?

• Can we customize note templates, section headers, and output formats per specialty or per clinician?

• How does the scribe handle specialty-specific workflows (e.g., mental status exams in psychiatry, review of systems in cardiology, developmental milestones in pediatrics)?

• Do you support different care settings: outpatient, inpatient, urgent care, telehealth, surgical pre-op?

• Can the scribe adapt to different documentation standards (SOAP, H&P, procedure notes, consult letters)?

What Good Answers Sound Like

A vendor with genuine specialty support will show you the template library, demonstrate how a psychiatry note differs structurally from a family medicine note, and explain how clinician preferences are stored and applied. They'll have documentation examples from your specialty—not just primary care. They'll describe a configuration process that happens during onboarding, not a "feature request" process that takes six months.

What Bad Answers Sound Like

• "Our AI is general-purpose—it adapts to any specialty automatically." General-purpose models produce generic notes. Specialty medicine requires specialty logic.

• "We're adding specialty support in our next release." If it's not live today, it doesn't help you today.

• "Clinicians can edit the note to fit their specialty needs." Again—editing is not adaptation. It's workaround.

Red Flags

• No specialty-specific templates available at launch

• Template customization requires vendor professional services at additional cost

• The vendor cannot demonstrate notes from your specialty generated in real clinical conditions

Scribing.io supports specialty-specific workflows across cardiology, psychiatry, pediatrics, and family medicine, with customizable templates that adapt to each clinician's documentation preferences.

How to Score Vendors Side by Side

Bringing structure to your evaluation means scoring each vendor consistently. Below is a simplified rubric you can adapt for your procurement committee:

Assign a score of 1 to 5 for each category based on vendor responses. Multiply by the weight to produce a weighted total. Compare vendors not just on total score but on any category where a vendor scores below 3—that's a risk zone that deserves additional scrutiny or a disqualifying threshold.

FAQ: Common Procurement Objections

Our clinicians are resistant to any new technology. Isn't this a waste of time?

Clinician resistance usually stems from past experiences with poorly implemented tools. An AI scribe that truly reduces documentation burden—without adding new steps—tends to achieve adoption faster than most health IT implementations. The key is choosing a product that fits existing workflows rather than requiring clinicians to change behavior. Insist on a pilot with voluntary participation and measure actual adoption, not mandated usage.

We already have human scribes. Why switch?

Human scribes deliver high-quality documentation, but they face scalability constraints: hiring, training, turnover, scheduling across shifts and locations, and cost per encounter that doesn't decrease with volume. AI scribes complement or extend human scribe coverage—they're available for every encounter, every telehealth visit, and every late-evening documentation session. Many organizations use AI scribes to cover the gaps where human scribes aren't economically feasible.

How do we handle clinicians who document in multiple languages?

Ask your vendor which languages the scribe supports for both audio capture and note generation. Some platforms handle multilingual encounters natively; others require the encounter to be conducted primarily in one language. This is especially important for practices with significant non-English-speaking patient populations.

What if the AI scribe makes an error that affects patient care?

This is why the clinician review step is non-negotiable. AI scribes generate draft documentation—the clinician remains the author of record and must review before signing. Your vendor should provide safeguards (confidence flags, required-field validation) that make review efficient, but the legal and clinical responsibility for the final note rests with the signing clinician. The CMS documentation integrity guidelines reinforce that the attesting provider is responsible for the accuracy of clinical documentation regardless of how it was generated.

Is an AI scribe a medical device that requires FDA clearance?

As of 2026, most AI scribes are classified as clinical documentation tools—not diagnostic or treatment-decision tools—and therefore fall outside FDA medical device regulation. However, if an AI scribe makes clinical suggestions, auto-generates orders, or influences treatment decisions, the regulatory classification may shift. Ask your vendor directly: "Does your product make clinical recommendations, or does it strictly document what was said during the encounter?"

Get Started Today

You now have the seven questions, the scoring rubric, and the red-flag checklist. The next step is to test a vendor against them. Scribing.io was built to withstand exactly this kind of scrutiny—with direct EHR integrations, specialty-specific workflows, transparent pricing, and a free trial that lets you evaluate in your own clinical environment before committing a dollar. Put us through your evaluation framework and see the results for yourself.

Start Your Free Trial — No Credit Card Required